Anticancer therapy
Abstract
A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.
- Inventors:
- Issue Date:
- Research Org.:
- STC.UNM, Albuquerque, NM (United States)
- Sponsoring Org.:
- USDOE
- OSTI Identifier:
- 1496591
- Patent Number(s):
- 10172967
- Application Number:
- 15/427,355
- Assignee:
- STC.UNM (Albuquerque, NM)
- Patent Classifications (CPCs):
-
A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- DOE Contract Number:
- FG01-001NE23554
- Resource Type:
- Patent
- Resource Relation:
- Patent File Date: 2017 Feb 08
- Country of Publication:
- United States
- Language:
- English
- Subject:
- 60 APPLIED LIFE SCIENCES
Citation Formats
Norenberg, Jeffrey P. Anticancer therapy. United States: N. p., 2019.
Web.
Norenberg, Jeffrey P. Anticancer therapy. United States.
Norenberg, Jeffrey P. Tue .
"Anticancer therapy". United States. https://www.osti.gov/servlets/purl/1496591.
@article{osti_1496591,
title = {Anticancer therapy},
author = {Norenberg, Jeffrey P.},
abstractNote = {A subject afflicted with a cancer or precancerous condition is treated by administering an agent that increases expression of somatostatin receptors, and a cytotoxic recognition ligand. In an alternative embodiment, somatostatin analogs, which are radiolabeled are used to treat cancer or precancerous conditions.},
doi = {},
journal = {},
number = ,
volume = ,
place = {United States},
year = {2019},
month = {1}
}
Save to My Library
You must Sign In or Create an Account in order to save documents to your library.
Works referenced in this record:
Treatment of damaged bone marrow and dosage units therefor
patent, July 1990
- Borch, Richard F.; Schmalbach, Therese K.
- US Patent Document 4,938,949
Preclinical Evaluation of the α-Particle Generator Nuclide 225Ac for Somatostatin Receptor Radiotherapy of Neuroendocrine Tumors
journal, June 2008
- Miederer, M.; Henriksen, G.; Alke, A.
- Clinical Cancer Research, Vol. 14, Issue 11, p. 3555-3561
Kidney protection during peptide receptor radionuclide therapy with somatostatin analogues
journal, November 2009
- Rolleman, Edgar; Melis, Marleen; Valkema, Roelf
- European Journal of Nuclear Medicine and Molecular Imaging, Vol. 37, Issue 5, p. 1018-1031
Somatostatin in the central nervous system: Physiology and pathological modifications
journal, January 1986
- Epelbaum, Jacques
- Progress in Neurobiology, Vol. 27, Issue 1
Peptide Receptors as Molecular Targets for Cancer Diagnosis and Therapy
journal, August 2003
- Reubi, Jean Claude
- Endocrine Reviews, Vol. 24, Issue 4
Biochemical and Functional Properties of Somatostatin Receptors
journal, June 1992
- Rens-Domiano, Stephanie; Reisine, Terry
- Journal of Neurochemistry, Vol. 58, Issue 6
Tumor Imaging and Therapy Using Radiolabeled Somatostatin Analogues
journal, July 2009
- de Jong, Marion; Breeman, Wout; Kwekkeboom, Dik
- Accounts of Chemical Research, Vol. 42, Issue 7, p. 873-880
Long-term toxicity of [177Lu-DOTA0,Tyr3]octreotate in rats
journal, September 2006
- Rolleman, Edgar; Krenning, Eric; Bernard, Bert
- European Journal of Nuclear Medicine and Molecular Imaging, Vol. 34, Issue 2, p. 219-227
Hypothalamic Polypeptide That Inhibits the Secretion of Immunoreactive Pituitary Growth Hormone
journal, January 1973
- Brazeau, P.; Vale, W.; Burgus, R.
- Science, Vol. 179, Issue 4068
Hypothalamic hormones: from neuroendocrinology to cancer therapy
journal, January 1994
- Schally, Andrew V.
- Anti-Cancer Drugs, Vol. 5, Issue 2
Cloning, Functional Expression and Pharmacological Characterization of a Fourth (hSSTR4) and a Fifth (hSSTR5) Human Somatostatin Receptor Subtype
journal, September 1993
- Yamada, Y.; Kagimoto, S.; Kubota, A.
- Biochemical and Biophysical Research Communications, Vol. 195, Issue 2
The clinical value of [90Y-DOTA]-D-Phe1-Tyr3-octreotide (90Y-DOTATOC) in the treatment of neuroendocrine tumours: A clinical phase II study
journal, July 2001
- Waldherr, C.; Pless, M.; Maecke, H.
- Annals of Oncology, Vol. 12, Issue 7, p. 941-945
RGD (Arg-Gly-Asp) coupled to (neuro)peptides
patent, April 2007
- DeJong, Marion; Krenning, Eric P.; Van Hagen, Petrus Martinus
- US Patent Document 7,202,330
Somatostatin Receptor Scintigraphy: Its Sensitivity Compared with That of Other Imaging Methods in Detecting Primary and Metastatic Gastrinomas: A Prospective Study
journal, July 1996
- Gibril, Fathia
- Annals of Internal Medicine, Vol. 125, Issue 1
A human somatostatin receptor (SSTR3), located on chromosome 22, displays preferential affinity for somatostatin-14 like peptides
journal, April 1993
- Corness, Jacquie D.; Demchyshyn, Lidia L.; Seeman, Philip
- FEBS Letters, Vol. 321, Issue 2-3
Somatostatin analogs for the treatment of cancer
patent, November 2001
- Burman, Anand C.; Prasad, Sudhanand; Mukherjee, Rama
- US Patent Document 6,316,414
Cyclic peptide somatostatin analogs
patent, August 1999
- Dean, Richard T.; McBride, William; Lister-James, John
- US Patent Document 5,932,189
Synthesis and biological activity of highly potent octapeptide analogs of somatostatin.
journal, March 1986
- Cai, R. Z.; Szoke, B.; Lu, R.
- Proceedings of the National Academy of Sciences, Vol. 83, Issue 6
Cell cycle disturbances and apoptosis induced by topotecan and gemcitabine on human lung cancer cell lines
journal, May 1999
- Tolis, C.; Peters, G. J.; Ferreira, C. G.
- European Journal of Cancer, Vol. 35, Issue 5
Conformationally constrained backbone cyclized somatostatin analogs
patent, April 2000
- Hornik, Vered; Gellerman, Gary; Afargan, Mich El M.
- US Patent Document 6,051,554
Clinical results of long‐term slow‐release lanreotide treatment of acromegaly
journal, April 1997
- Giusti, M.; Ciccarelli, E.; Dallabonzana, D.
- European Journal of Clinical Investigation, Vol. 27, Issue 4
Complexes of functionalized tetraazacyclododecane chelates with bismuth, lead, ytriium, actinium, or lanthanide metal ions
patent, June 1995
- Gansow, Otto A.; Brechbiel, Martin W.; Magerstadt, Michael
- US Patent Document 5,428,154
A potent cyclic hexapeptide analogue of somatostatin
journal, July 1981
- Veber, Daniel F.; Freidinger, Roger M.; Perlow, Debra Schwenk
- Nature, Vol. 292, Issue 5818
In vitro detection of somatostatin receptors in human tumors
journal, September 1992
- Reubi, J. C.; Krenning, E.; Lamberts, S. W. J.
- Metabolism, Vol. 41, Issue 9
Bifunctional chelating agents
patent, October 1991
- Johnson, David K.; Kline, Steven J.
- US Patent Document 5,057,302
Treatment with 90Y- and 177Lu-DOTATOC in patients with metastatic neuroendocrine tumors
journal, December 2006
- Frilling, Andrea; Weber, Frank; Saner, Fuat
- Surgery, Vol. 140, Issue 6, p. 968-977
Glossary of terms used in medicinal chemistry (IUPAC Recommendations 1998)
journal, January 1998
- Wermuth, C. G.; Ganellin, C. R.; Lindberg, P.
- Pure and Applied Chemistry, Vol. 70, Issue 5
Experimental facts supporting a red marrow uptake due to radiometal transchelation in 90Y-DOTATOC therapy and relationship to the decrease of platelet counts
journal, February 2011
- Walrand, Stephan; Barone, Raffaella; Pauwels, Stanislas
- European Journal of Nuclear Medicine and Molecular Imaging, Vol. 38, Issue 7, p. 1270-1280
Conformationally constrained backbone cyclized somatostatin analogs
patent, August 2005
- Hornik, Vered; Afargan, Michel; Gellerman, Gary
- US Patent Document 6,930,088
Peptide compounds having improved binding affinity to somatostatin receptors
patent, October 2006
- Macke, Helmut; Reubi, Jean Claude; Schmitt, Jörg
- US Patent Document 7,122,622
Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
journal, February 1998
- Nagy, A.; Schally, A. V.; Halmos, G.
- Proceedings of the National Academy of Sciences, Vol. 95, Issue 4
RAPID COMMUNICATION: Human Ovarian Cancers Express Somatostatin Receptors
journal, October 2000
- Halmos, Gabor; Sun, Baodong; Schally, Andrew V.
- The Journal of Clinical Endocrinology & Metabolism, Vol. 85, Issue 10
Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney.
journal, January 1992
- Yamada, Y.; Post, S. R.; Wang, K.
- Proceedings of the National Academy of Sciences, Vol. 89, Issue 1
Long-term evaluation of renal toxicity after peptide receptor radionuclide therapy with 90Y-DOTATOC and 177Lu-DOTATATE: the role of associated risk factors
journal, April 2008
- Bodei, Lisa; Cremonesi, Marta; Ferrari, Mahila
- European Journal of Nuclear Medicine and Molecular Imaging, Vol. 35, Issue 10, p. 1847-1856
Combined Modality Therapy of Gemcitabine and Radiation
journal, January 2005
- Pauwels, B.
- The Oncologist, Vol. 10, Issue 1
Somatostatin Receptors in Pituitary and Development of Somatostatin Receptor Subtype-Selective Analogs
journal, January 2003
- Shimon, Ilan
- Endocrine, Vol. 20, Issue 3
Somatostatin receptor scintigraphy with [111In-DTPA-d-Phe1]- and [123I-Tyr3]-octreotide: the Rotterdam experience with more than 1000 patients
journal, August 1993
- Krenning, E. P.; Kwekkeboom, D. J.; Bakker, W. H.
- European Journal of Nuclear Medicine, Vol. 20, Issue 8
Receptor Radionuclide Therapy with 90Y-DOTATOC in Patients with Medullary Thyroid Carcinomas
journal, February 2004
- Bodei, Lisa; Handkiewicz-Junak, Daria; Grana, Chiara
- Cancer Biotherapy & Radiopharmaceuticals, Vol. 19, Issue 1, p. 65-71
Internalization of [DOTAo,125I-Tyr3]Octreotide by Somatostatin Receptor-Positive Cells In Vitro and In Vivo: Implications for Somatostatin Receptor-Targeted Radio-guided Surgery
journal, January 1999
- Hof land, Leo J.; Breeman, Wout A. P.; Krenning, Eric P.
- Proceedings of the Association of American Physicians, Vol. 111, Issue 1
Targeted radiotherapy for small cell lung cancer using 90Yttrium-DOTATOC, an Yttrium-labelled somatostatin analogue: a pilot trial
journal, September 2004
- Pless, Miklos; Waldherr, Christian; Maecke, Helmut
- Lung Cancer, Vol. 45, Issue 3, p. 365-371
SMS 201–995: A very potent and selective octapeptide analogue of somatostatin with prolonged action
journal, September 1982
- Bauer, Wilfried; Briner, Ulrich; Doepfner, Wolfgang
- Life Sciences, Vol. 31, Issue 11
A Comparison of High- Versus Low-Linear Energy Transfer Somatostatin Receptor Targeted Radionuclide Therapy In Vitro
journal, February 2005
- Nayak, Tapan; Norenberg, Jeffrey; Anderson, Tamara
- Cancer Biotherapy and Radiopharmaceuticals, Vol. 20, Issue 1
Yttrium-90 DOTATOC: first clinical results
journal, October 1999
- Otte, A.; Herrmann, R.; Heppeler, A.
- European Journal of Nuclear Medicine and Molecular Imaging, Vol. 26, Issue 11, p. 1439-1447
The Enzyme Ribonucleotide Reductase: Target for Antitumor and Anti-HIV Therapy
journal, January 1997
- Szekeres, Thomas; Fritzer-Szekeres, Monika; Elford, Howard L.
- Critical Reviews in Clinical Laboratory Sciences, Vol. 34, Issue 6
Nephrotoxicity in Mice After Repeated Imaging Using 111In-Labeled Peptides
journal, May 2010
- Melis, M.; Vegt, E.; Konijnenberg, M.
- Journal of Nuclear Medicine, Vol. 51, Issue 6, p. 973-977
213Bi-[DOTA0, Tyr3]Octreotide Peptide Receptor Radionuclide Therapy of Pancreatic Tumors in a Preclinical Animal Model
journal, February 2006
- Norenberg, J. P.
- Clinical Cancer Research, Vol. 12, Issue 3
Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues
journal, December 2005
- Kaltsas, G. A.; Papadogias, D.; Makras, P.
- Endocrine-Related Cancer, Vol. 12, Issue 4
Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findings
journal, April 2002
- de Jong, Marion; Valkema, Roelf; Jamar, Francois
- Seminars in Nuclear Medicine, Vol. 32, Issue 2, p. 133-140
A new peptidic somatostatin agonist with high affinity to all five somatostatin receptors
journal, December 2002
- Reubi, Jean Claude; Eisenwiener, Klaus-Peter; Rink, Hans
- European Journal of Pharmacology, Vol. 456, Issue 1-3
Power-on reset circuit device for multi-level power supply sources
patent, May 1993
- Nagai, Nobutaka
- US Patent Document 5,214,316
Phase I Trial of 90Y-DOTATOC Therapy in Children and Young Adults with Refractory Solid Tumors That Express Somatostatin Receptors
journal, September 2010
- Menda, Y.; O'Dorisio, M.; Kao, S.
- Journal of Nuclear Medicine, Vol. 51, Issue 10, p. 1524-1531
Receptor Targeting for Tumor Localisation and Therapy with Radiopeptides
journal, September 2000
- Heppeler, A.; Froidevaux, S.; Eberle, A.
- Current Medicinal Chemistry, Vol. 7, Issue 9
Radiolabeled Somatostatin Analog [ 177 Lu-DOTA 0 ,Tyr 3 ]Octreotate in Patients With Endocrine Gastroenteropancreatic Tumors
journal, April 2005
- Kwekkeboom, Dik J.; Teunissen, Jaap J.; Bakker, Willem H.
- Journal of Clinical Oncology, Vol. 23, Issue 12
Octreotide
journal, January 1996
- Lamberts, Steven W. J.; van der Lely, Aart-Jan; de Herder, Wouter W.
- New England Journal of Medicine, Vol. 334, Issue 4
Somatostatin Receptor-Based Scintigraphy and Antitumor Treatment--An Expanding Vista?
journal, October 2000
- Jensen, R. T.
- Journal of Clinical Endocrinology & Metabolism, Vol. 85, Issue 10
Vapreotide, a new somatostatin analogue in the palliative management of obstructive ileus in advanced cancer
journal, January 1993
- Stiefel, Friedrich; Morant, Rudolf
- Supportive Care in Cancer, Vol. 1, Issue 1
Highly sensitive multimeric nucleic acid probes
patent, June 2000
- Kool, Eric T.
- US Patent Document 6,077,668
Therapy using labelled somatostatin analogues: comparison of the absorbed doses with 111In-DTPA-D-Phe1-octreotide and yttrium-labelled DOTA-D-Phe1-Tyr3-octreotide
journal, January 2008
- Barone, Raffaella; Walrand, Stéphan; Konijnenberg, Mark
- Nuclear Medicine Communications, Vol. 29, Issue 3, p. 283-290
Assessment of Hepatic Toxicity from Treatment with 90Y-SMT 487 (OctreoTher™) in Patients with Diffuse Somatostatin Receptor Positive Liver Metastases
journal, August 2003
- Bushnell, David; Menda, Yusuf; Madsen, Mark
- Cancer Biotherapy & Radiopharmaceuticals, Vol. 18, Issue 4, p. 581-588
4-Step Renal Dosimetry Dependent on Cortex Geometry Applied to 90Y Peptide Receptor Radiotherapy: Evaluation Using a Fillable Kidney Phantom Imaged by 90Y PET
journal, November 2010
- Walrand, S.; Jamar, F.; van Elmbt, L.
- Journal of Nuclear Medicine, Vol. 51, Issue 12
Somatostatin analogs
patent, March 2002
- Lister-James, John; Dean, Richard T.; Pearson, Daniel A.
- US Patent Document 6,358,491
90Y-DOTA-D-Phe1-Try3- octreotide in therapy of neuroendocrine malignancies
journal, January 2002
- Paganelli, G.; Bodei, L.; Handkiewicz Junak, D.
- Biopolymers, Vol. 66, Issue 6, p. 393-398
Lymphocytic Toxicity in Patients After Peptide-Receptor Radionuclide Therapy (PRRT) with 177Lu-DOTATATE and 90Y-DOTATOC
journal, December 2009
- Sierra, Maribel; Agazzi, Alberto; Bodei, Lisa
- Cancer Biotherapy & Radiopharmaceuticals, Vol. 24, Issue 6, p. 659-665
Somatostatin and Its Receptor Family
journal, July 1999
- Patel, Yogesh C.
- Frontiers in Neuroendocrinology, Vol. 20, Issue 3
Phase I study of peptide receptor radionuclide therapy with [111In-DTPA0]octreotide: The rotterdam experience
journal, April 2002
- Valkema, Roelf; de Jong, Marion; Bakker, Willem H.
- Seminars in Nuclear Medicine, Vol. 32, Issue 2, p. 110-122